Reviewing TBG Diagnostics (OTCMKTS:TDLAF) and FitLife Brands (NASDAQ:FTLF)

TBG Diagnostics (OTCMKTS:TDLAF) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, institutional ownership and valuation.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for TBG Diagnostics and FitLife Brands, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TBG Diagnostics	0	0	0	0	N/A
FitLife Brands	0	0	1	1	3.50

FitLife Brands has a consensus target price of $40.00, suggesting a potential upside of 20.55%. Given FitLife Brands’ higher possible upside, analysts plainly believe FitLife Brands is more favorable than TBG Diagnostics.

Volatility and Risk

TBG Diagnostics has a beta of -12.38, suggesting that its share price is 1,338% less volatile than the S&P 500. Comparatively, FitLife Brands has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.

Valuation and Earnings

This table compares TBG Diagnostics and FitLife Brands’ gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TBG Diagnostics	$2.33 million	1.02	$530,000.00	N/A	N/A
FitLife Brands	$60.68 million	2.51	$5.30 million	$1.48	22.42

FitLife Brands has higher revenue and earnings than TBG Diagnostics.

Profitability

This table compares TBG Diagnostics and FitLife Brands’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TBG Diagnostics	N/A	N/A	N/A
FitLife Brands	13.12%	28.06%	15.02%

Institutional and Insider Ownership

2.3% of FitLife Brands shares are held by institutional investors. 3.6% of TBG Diagnostics shares are held by company insiders. Comparatively, 61.2% of FitLife Brands shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

FitLife Brands beats TBG Diagnostics on 12 of the 12 factors compared between the two stocks.

About TBG Diagnostics

TBG Diagnostics Limited, a molecular diagnostics company, develops, manufactures, and markets molecular diagnostics kits, instruments, and services in Taiwan and China. It provides ExProbe HLA and HPA kits for human leukocyte antigen (HLA) and human platelet antigens (HPA) allele genotyping, which uses real time polymerase chain reaction (PCR) techniques with sequence specific primers and probes; Morgan SSP HLA kits for determining HLA alleles using PCR techniques with sequence specific primers; HLAssure SBT HLA Kits for transplantation donor selection; and AccuType SBT analysis software to analyze sequences from all ab1 based files. The company also offers Morgan SSPal HLA Typing Analysis Software, a gel result interpretation software; HLA typing services that offer low to high resolution using PCR fragment analysis (SSP) and DNA sequencing (SBT); QPCR Q6000, a six-channel real time PCR instrument; QzNGS NGS that provides high resolution HLA genotyping; and COVID-19 testing kits. It serves clinical labs, blood centers, and bone marrow registry labs. The company was formerly known as Progen Pharmaceuticals Limited and changed its name to TBG Diagnostics Limited in December 2015. TBG Diagnostics Limited was incorporated in 1989 is based in Greenslopes, Australia.

About FitLife Brands

FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; sports nutrition products; weight loss and sports nutrition products; sports nutrition and general wellness formulations with an emphasis on natural, vegan, and organic ingredients; and male health and weight loss products, as well as other diet, health, and sports nutrition supplements and related products; and value-oriented sports nutrition and weight loss products. It offers MRC products which includes general health supplements; and natural skincare and beauty products. In addition, it markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Dr. Tobias, All-Natural Advice, and Maritime Naturals through franchised stores, as well as through retail locations, which include specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.